NCT04490317 CARbon monoxidE intoxiCatiOn in Korea: Prospective Cohort (CARE CO Cohort)
| NCT ID | NCT04490317 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wonju Severance Christian Hospital |
| Condition | Carbon Monoxide Poisoning |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,500 participants |
| Start Date | 2020-07-29 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,500 participants in total. It began in 2020-07-29 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This prospective cohort study enrolls subjects who experience carbon monoxide (CO) poisoning. The purpose of the study is to evaluate therapeutic effects of various treatments and short and long-term outcomes in CO poisoned patients. In addition, complications of brain and heart susceptible to CO are investigated through various ways and the association between complications and the patient's prognosis is also investigated. All subjects will be regularly monitored by physicians participating in this study.
Eligibility Criteria
Inclusion Criteria: * Acute CO poisoning Exclusion Criteria: * Declined to enrollment in the study
Contact & Investigator
Yong Sung Cha, MD
PRINCIPAL INVESTIGATOR
Wonju Severance Christian Hospital
Frequently Asked Questions
Who can join the NCT04490317 clinical trial?
This trial is open to participants of all sexes, studying Carbon Monoxide Poisoning. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04490317 currently recruiting?
Yes, NCT04490317 is actively recruiting participants. Contact the research team at emyscha@yonsei.ac.kr for enrollment information.
Where is the NCT04490317 trial being conducted?
This trial is being conducted at Wŏnju, South Korea.
Who is sponsoring the NCT04490317 clinical trial?
NCT04490317 is sponsored by Wonju Severance Christian Hospital. The principal investigator is Yong Sung Cha, MD at Wonju Severance Christian Hospital. The trial plans to enroll 1,500 participants.